Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beránek

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Vnitrni Lekarstvi|August 19, 2007
[The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI)]J Olsovský, M Beránek
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|November 18, 1998
[Pharmacologic importance of glycation of plasma proteins]M Beránek, V Palicka
Molecular and Cellular Probes|September 6, 2000
Identification of novel common polymorphisms in the promoter region of the TIMP-3 gene in Czech populationM Beránek, K Kanková, J Muzík
Molecular and Cellular Biochemistry|May 2, 2001
Inhibitory effect of glycation on catalytic activity of alanine aminotransferaseM Beránek, J Drsata, V Palicka
Casopis Lekaru Ceskych|November 24, 1999
[Heterogeneity of the frequency of the apolipoprotein E-epsilon 4 allele in the European population]M Beránek, B Friedecký, V Palicka
European Journal of Clinical Pharmacology|February 24, 2001
In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasmaJ Chládek, G Zimová, M Beránek, et al.
Vnitrni Lekarstvi|January 25, 2006
[The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency]V Olsovská, H Siprová, M Beránek, et al.
Vnitrni Lekarstvi|November 10, 2006
[Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase]J Voglová, V Maisnar, M Beránek, et al.
Folia Biologica|July 28, 2015
Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic VariantsM Beránek, M Drastíková, J Bureš, et al.
Casopis Lekaru Ceskych|February 14, 2006
[Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia]M Beránek, J Voglová, A Sýkorová, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Vnitrni Lekarstvi|August 19, 2007
[The influence of long-term therapy with the insulin pump (CSII) in patients with type 1 diabetes mellitus on metabolic compensation and on the incidence of hypoglycaemia. Comparison with intensified conventional insulin therapy (MDI)]J Olsovský, M Beránek
Ceska a Slovenska Farmacie : Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti|November 18, 1998
[Pharmacologic importance of glycation of plasma proteins]M Beránek, V Palicka
Molecular and Cellular Probes|September 6, 2000
Identification of novel common polymorphisms in the promoter region of the TIMP-3 gene in Czech populationM Beránek, K Kanková, J Muzík
Molecular and Cellular Biochemistry|May 2, 2001
Inhibitory effect of glycation on catalytic activity of alanine aminotransferaseM Beránek, J Drsata, V Palicka
Casopis Lekaru Ceskych|November 24, 1999
[Heterogeneity of the frequency of the apolipoprotein E-epsilon 4 allele in the European population]M Beránek, B Friedecký, V Palicka
European Journal of Clinical Pharmacology|February 24, 2001
In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasmaJ Chládek, G Zimová, M Beránek, et al.
Vnitrni Lekarstvi|January 25, 2006
[The influence of long-term growth hormone replacement therapy on body composition, bone tissue and some metabolic parameters in adults with growth hormone deficiency]V Olsovská, H Siprová, M Beránek, et al.
Vnitrni Lekarstvi|November 10, 2006
[Combination of imatinib and anagrelide in treatment of chronic myeloid leukemia in blastic phase]J Voglová, V Maisnar, M Beránek, et al.
Folia Biologica|July 28, 2015
Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic VariantsM Beránek, M Drastíková, J Bureš, et al.
Casopis Lekaru Ceskych|February 14, 2006
[Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia]M Beránek, J Voglová, A Sýkorová, et al.
Pageof 4